Nektar Therapeutics
Howard W. Robin, President and Chief Executive Officer
Stephen K. Doberstein, Ph.D., Senior Vice President and Chief Scientific Officer
Rinko Ghosh, Senior Vice President and Chief Business Officer
Dorian Hirth, Senior Vice President, Human Resources and Facilities Operations
Maninder Hora, Ph.D., Senior Vice President, Pharmaceutical Development and Manufacturing Operations
Gil M. Labrucherie, Senior Vice President, General Counsel and Secretary
Robert Medve, M.D., Senior Vice President and Chief Medical Officer
John Nicholson, Senior Vice President and Chief Financial Officer
Timothy A. Riley, Ph.D., Senior Vice President, Technology Assessment and Quality Assurance
Jillian B. Thomsen, Senior Vice President, Finance and Chief Accounting Officer
Robert B. Chess, Chairman of the Board, Nektar Therapeutics, OPX Biotechnologies and Germitec SAS
R. Scott Greer, Managing Director, Numenor Ventures, LLC
Joseph J. Krivulka, Co-founder and Chief Executive Officer, Akrimax Pharmaceuticals, LLC
Christopher A. Kuebler, Former Chairman, Covance Inc.
Lutz Lingnau, Former Executive Board Member, Schering AG
Howard W. Robin, President and Chief Executive Officer, Nektar Therapeutics
Susan Wang, Former Chief Financial Officer, Solectron
Roy A. Whitfield, Former Chairman and Chief Executive Officer, Incyte Corporation
Dennis Winger, Former Senior Vice President and CFO, Applera Corporation